Andrew J.K. Östör

Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase <scp>III</scp>, Double‐Blind, Randomized Controlled Trial

Roy Fleischmann, Aileen L. Pangan, In‐Ho Song et al. · Arthritis & Rheumatology · 2019 · 410 citations

Diagnosis and relation to general health of shoulder disorders presenting to primary care

Andrew J.K. Östör, C. Richards, A Toby Prevost et al. · Lara D. Veeken · 2005 · 409 citations · Full text

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies

T. Ding, Jo Ledingham, Raashid Luqmani et al. · Lara D. Veeken · 2010 · 213 citations

Immunology, Arthritis Guidelines, Pharmacotherapy +16

Anti-Tumor Necrosis Factor-α Therapy Reduces Aortic Inflammation and Stiffness in Patients With Rheumatoid Arthritis

Kaisa Mäki-Petäjä, Maysoon Elkhawad, Joseph Cheriyan et al. · Circulation · 2012 · 212 citations

Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response

Roy Fleischmann, Mark C. Genovese, Jeffrey Enejosa et al. · Annals of the Rheumatic Diseases · 2019 · 164 citations · Full text